Young‐Hyeon An

Young‐Hyeon An

Auto-generated profile, based on publicly available information

Young‐Hyeon An

BioMAX/N‐Bio Institute Institute of Bio‐Engineering Seoul National University Seoul 08826 Republic of Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2023 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
DLDong-Yup Lee
Dong-Yup Lee
SASivashanmugam Amirthalingam
Sivashanmugam Amirthalingam
CLChangyub Lee
Changyub Lee
ARArun Kumar Rajendran
Arun Kumar Rajendran
YAYoung-Hyun Ahn
Young-Hyun Ahn
Nathaniel HwangNathaniel Hwang
Nathaniel Hwang
Gene therapy is a promising approach for the treatment of many diseases. However, the effective delivery of the cargo without degradation in vivo is one of the major hurdles. With the advent of lipid nanoparticles (LNPs) and cell-derived nanovesicles (CDNs), gene delivery holds a very promising future. The targeting of these nanosystems is a prerequisite for effective transfection with minimal side-effects. In this review, we highlight the emerging strategies utilized for the effective targeting of LNPs and CDNs, and we summarize the preparation methodologies for LNPs and CDNs. We have also highlighted the non-ligand targeting of LNPs toward certain organs based on their composition. It is highly expected that continuing the developments in the targeting approaches of LNPs and CDNs for the delivery system will further promote them in clinical translation.

5 January 2022 in Advanced Science
Verified
Journal Article
Open access
PDF file
ULUk-Jae Lee
Uk-Jae Lee
JKJunghyeon Ko
Junghyeon Ko
SKSu-Hwan Kim
Su-Hwan Kim
PLPyung-Gang Lee
Pyung-Gang Lee
YAYoung‐Hyeon An
Young‐Hyeon An
Byung-Gee KimByung-Gee Kim
Byung-Gee Kim
Tyrosinase‐mediated melanin synthesis is an essential biological process that can protect skin from UV radiation and radical species. This work reports on in situ biosynthesis of artificial melanin in native skin using photoactivatable tyrosinase (PaTy). The I41Y mutant of Streptomyces avermitilis tyrosinase (SaTy) shows enzymatic activity comparable to that of wild‐type SaTy. This Y41 is replaced with photocleavable o‐nitrobenzyl tyrosine (ONBY) using the introduction of amber codon and ONBY‐tRNA synthetase/tRNA pairs. The ONBY efficiently blocks the active site and tyrosinase activity is rapidly recovered by the photo‐cleavage of ONBY. The activated PaTy successfully oxidizes L‐tyrosine and tyramine‐conjugated hyaluronic acid (HA_T) to synthesize melanin particles and hydrogel, respectively. To produce artificial melanin in living tissues, PaTy is encapsulated into lipid nanoparticles as an artificial melanosome. Using liposomes containing PaTy (PaTy_Lip), PaTy is transdermally delivered into ex vivo porcine skin and in vivo mouse skin tissues, thus achieving the in situ biosynthesis of artificial melanin for skin tissue protection under UV irradiation. The results of this study demonstrate that this biomimetic system can recapitulate the biosynthetic analogs of naturally occurring melanin. It should therefore be considered to be a promising strategy for producing protective biological molecules within living systems for tissue protection.

16 July 2024 in Small Science
Verified
Journal Article
Open access
JKJunghyeon Ko
Junghyeon Ko
JKJeong‐Uk Kim
Jeong‐Uk Kim
SCSubin Choi
Subin Choi
YKYe‐Sol Kim
Ye‐Sol Kim
SPSu‐Bin Park
Su‐Bin Park
Nathaniel HwangNathaniel Hwang
Nathaniel Hwang
Protein therapeutics are emerging as essential technologies due to their functional and chemical properties. However, their application is currently limited to delivery by oral and injection methods—the former being inefficient and the latter invasive and potentially tissue damaging. Researchers are, therefore, exploring noninvasive delivery systems for proteins through the skin, including transdermal and topical delivery. The large molecular size of proteins presents a key challenge for skin penetration, hindering their ability to penetrate the dense skin lamellar structure. This review focuses on using nanoparticles as carriers to increase protein stability and enhance skin penetration. The use of noninvasive or minimally invasive enhancers for controlling and improving penetration depth is also examined. Furthermore, the physical properties of nanoparticles that affect delivery are evaluated, aiming to propose ways to advance transdermal and topical delivery methods in the future.

11 August 2021 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
MPMihn Jeong Park
Mihn Jeong Park
YAYoung‐Hyeon An
Young‐Hyeon An
YCYoung Hwan Choi
Young Hwan Choi
HKHwan D. Kim
Hwan D. Kim
Nathaniel HwangNathaniel Hwang
Nathaniel Hwang

24 November 2018
Verified
Book Chapter
Closed access
PDF file
HKHyunbum Kim
Hyunbum Kim
SKSeung-Hyun L. Kim
Seung-Hyun L. Kim
YCYoung-Hwan Choi
Young-Hwan Choi
YAYoung-Hyun Ahn
Young-Hyun Ahn
Nathaniel HwangNathaniel Hwang
Nathaniel Hwang

27 December 2023 in Advanced Therapeutics
Verified
Journal Article
Closed access
ESEunhye Shin
Eunhye Shin
JKJeong‐Uk Kim
Jeong‐Uk Kim
JKJunghyeon Ko
Junghyeon Ko
RKRachel H. Koh
Rachel H. Koh
JKJunhee Kim
Junhee Kim
Nathaniel HwangNathaniel Hwang
Nathaniel Hwang